Instead, it suppressed c‐Jun activation through the AKT‐SP1‐NGFR signalling pathway, resulting in decreased inflammatory responses in KCs and marked improvement in psoriasis‐like lesions. This evidence concerns the gene AKT1 and dry eye syndrome.